Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | May 26, 2026 | May 28, 2026 |
| Cencora, Inc.COR · Entity 2994 | Director · Executive Chairman | September 16, 2025 | September 18, 2025 |
| Elevance Health, Inc.ELV · Entity 2934 | Director | May 13, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 42,003 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 15,842 · Balance 42,003 F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.
Cencora, Inc.
Report date September 16, 2025 · Filed September 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 305,912.665 |
Ending reported balance
After 2025-09-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-09-16 · Exercise / conversion · Acquired 29,350 · Balance 337,262.665 Row 2 · 2025-09-16 · Sale · Disposed 31,350 · Balance 305,912.665 F1: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 11/25/24. F2: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple tranches ranging from $287.372 to $292.625 inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in the footnote. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.09 · Expires 2026-11-13 | Direct | 58,699 |
Reported balance
After 2025-09-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-09-16 · Exercise / conversion · Disposed 29,350 · Balance 58,699 F3: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 11/25/24.
F2: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple tranches ranging from $287.372 to $292.625 inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in the footnote.
F3: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.
Elevance Health, Inc.
Report date May 13, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,202 |
Reported balance
After 2026-05-13 transaction · row 1
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 563 · Balance 4,202 F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 21:02 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 15,842 | $15.78 | $249,986.76 |
DisclosureSEC source: 0001860742-26-000076 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,003 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:10 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001191508-26-000004 · wk-form4_1778875844.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,202 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| April 30, 2026 Filed May 1, 2026 20:14 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,415 | $15.90 | $22,498.50 |
DisclosureSEC source: 0001860742-26-000064 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,161 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 13:03 UTC | Elevance Health, Inc. ELV · Entity 2934 | PurchaseCommon Stock | 3,000 | $289.84 | $869,520.00 |
DisclosureSEC source: 0001191508-26-000002 · wk-form4_1772802204.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,639 Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:23 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 4,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000022 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,746 F2 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances). Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:23 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | PurchaseCommon Shares, No Par Value | 15,000 | $17.81 | $267,150.00 |
DisclosureSEC source: 0001860742-26-000022 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,255 F1 · price: Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.77 to $17.85 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:19 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 5,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000019 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,255 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 19:56 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 29,350 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001191508-25-000011 · wk-form4_1758225390.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,699 Underlying: Common Stock · 29,350 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 19:56 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 31,350 | $289.86 | $9,087,142.35 |
DisclosureSEC source: 0001191508-25-000011 · wk-form4_1758225390.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 305,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 11/25/24. F2 · price: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple tranches ranging from $287.372 to $292.625 inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in the footnote. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 19:56 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 29,350 | $86.09 | $2,526,741.50 |
DisclosureSEC source: 0001191508-25-000011 · wk-form4_1758225390.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 337,262.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 20:08 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 12,579 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001191508-25-000007 · wk-form4_1755720506.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,049 Underlying: Common Stock · 12,579 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 20:08 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 14,579 | $289.98 | $4,227,618.42 |
DisclosureSEC source: 0001191508-25-000007 · wk-form4_1755720506.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 11/25/24. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 20:08 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 12,579 | $86.09 | $1,082,926.11 |
DisclosureSEC source: 0001191508-25-000007 · wk-form4_1755720506.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 322,491.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:18 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 639 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-25-000124 · wk-form4_1754425101.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 639 F1 · shares: Phantom Stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of the annual meeting of shareholders that immediately precedes the Director's election date or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| July 22, 2025 Filed Jul 23, 2025 20:30 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 12,578 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001191508-25-000005 · wk-form4_1753302613.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,628 Underlying: Common Stock · 12,578 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| July 22, 2025 Filed Jul 23, 2025 20:30 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 14,578 | $292.67 | $4,266,543.26 |
DisclosureSEC source: 0001191508-25-000005 · wk-form4_1753302613.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 309,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/25/24. Read SEC document |
| July 22, 2025 Filed Jul 23, 2025 20:30 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 12,578 | $86.09 | $1,082,840.02 |
DisclosureSEC source: 0001191508-25-000005 · wk-form4_1753302613.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 324,490.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2025 Filed Jun 25, 2025 20:03 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 12,579 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-25-000111 · wk-form4_1750881820.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,206 Underlying: Common Stock · 12,579 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| June 24, 2025 Filed Jun 25, 2025 20:03 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 14,579 | $292.62 | $4,266,106.98 |
DisclosureSEC source: 0001140859-25-000111 · wk-form4_1750881820.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 311,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/25/24. Read SEC document |
| June 24, 2025 Filed Jun 25, 2025 20:03 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 12,579 | $86.09 | $1,082,926.11 |
DisclosureSEC source: 0001140859-25-000111 · wk-form4_1750881820.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 326,491.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:00 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 12,578 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-25-000087 · wk-form4_1747857638.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,785 Underlying: Common Stock · 12,578 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:00 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 14,578 | $293.84 | $4,283,599.52 |
DisclosureSEC source: 0001140859-25-000087 · wk-form4_1747857638.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 313,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/25/24. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:00 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 12,578 | $86.09 | $1,082,840.02 |
DisclosureSEC source: 0001140859-25-000087 · wk-form4_1747857638.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 328,490.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2025 Filed Apr 23, 2025 20:24 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 12,579 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-25-000070 · wk-form4_1745439881.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,363 Underlying: Common Stock · 12,579 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| April 22, 2025 Filed Apr 23, 2025 20:24 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 14,579 | $281.81 | $4,108,507.99 |
DisclosureSEC source: 0001140859-25-000070 · wk-form4_1745439881.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 315,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/25/24. Read SEC document |
| April 22, 2025 Filed Apr 23, 2025 20:24 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 12,579 | $86.09 | $1,082,926.11 |
DisclosureSEC source: 0001140859-25-000070 · wk-form4_1745439881.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 330,491.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 20:40 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 12,578 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-25-000066 · wk-form4_1743021607.xml · derivative · entry 4 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,942 Underlying: Common Stock · 12,578 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 20:40 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 2,000 | $269.51 | $539,020.00 |
DisclosureSEC source: 0001140859-25-000066 · wk-form4_1743021607.xml · nonDerivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 317,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/25/24. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 20:40 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 12,578 | $269.51 | $3,389,896.78 |
DisclosureSEC source: 0001140859-25-000066 · wk-form4_1743021607.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 319,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/25/24. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 20:40 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 12,578 | $86.09 | $1,082,840.02 |
DisclosureSEC source: 0001140859-25-000066 · wk-form4_1743021607.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 332,490.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:05 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 12,579 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-25-000038 · wk-form4_1740776734.xml · derivative · entry 4 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 163,520 Underlying: Common Stock · 12,579 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:05 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 12,579 | $251.08 | $3,158,335.32 |
DisclosureSEC source: 0001140859-25-000038 · wk-form4_1740776734.xml · nonDerivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 319,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/25/24. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:05 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 12,579 | $86.09 | $1,082,926.11 |
DisclosureSEC source: 0001140859-25-000038 · wk-form4_1740776734.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 332,491.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:05 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 2,000 | $251.08 | $502,160.00 |
DisclosureSEC source: 0001140859-25-000038 · wk-form4_1740776734.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 319,912.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/25/24. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 21:11 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 395 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000189 · wk-form4_1734729090.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,474 Underlying: Common Stock · 395 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. F2 · shares: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/20/2025 to cover FICA obligation and associated income taxes for retirement eligible employees on 2024 grant of restricted stock units. F1 · derivative.exercise_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. F1 · derivative.expiration_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 21:11 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 395 | $232.24 | $91,734.80 |
DisclosureSEC source: 0001140859-24-000189 · wk-form4_1734729090.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,912.665 F2 · kind: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/20/2025 to cover FICA obligation and associated income taxes for retirement eligible employees on 2024 grant of restricted stock units. F3 · price: The closing price of the Company's common stock on 12/18/2024, the date used to calculate the FICA tax obligation in accordance with IRS rules. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 21:11 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 395 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000189 · wk-form4_1734729090.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,307.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 21:31 UTC | Cencora, Inc. COR · Entity 2994 | GiftCommon Stock | 4,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000179 · wk-form4_1732656706.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,912.665 F2 · shares: On November 25, 2024, the reporting person donated 4,644 shares of directly owned shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 21:31 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 50,000 | $243.98 | $12,198,750.00 |
DisclosureSEC source: 0001140859-24-000179 · wk-form4_1732656706.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,556.665 F1 · price: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $243.80 to $244.55, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. Read SEC document |
| November 21, 2024 Filed Nov 22, 2024 21:11 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 53,723 | $225.08 | $12,091,972.84 |
DisclosureSEC source: 0001140859-24-000164 · wk-form4_1732309864.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 376,556.665 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of performance share units. Read SEC document |
| November 21, 2024 Filed Nov 22, 2024 21:11 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 123,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000164 · wk-form4_1732309864.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,279.665 F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:11 UTC | Cencora, Inc. COR · Entity 2994 | GrantRestricted Stock Units · Derivative | 9,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000164 · wk-form4_1732309864.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,869 Underlying: Common Stock · 9,869 shares Expires not disclosed F3 · derivative.exercise_price: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. F3 · derivative.exercise_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. F3 · derivative.expiration_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:49 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 21,509 | $0.00 Strike: $89.58 | $0.00 |
DisclosureSEC source: 0001140859-24-000162 · wk-form4_1732225755.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,509 shares Expires 2025-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:49 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 21,509 | $242.16 | $5,208,619.44 |
DisclosureSEC source: 0001140859-24-000162 · wk-form4_1732225755.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,751.665 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/18/2023 and disclosed in the Company's Form 8-K filed with the Securities and Exchange Commission on 12/21/2023. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:49 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 21,509 | $89.58 | $1,926,776.22 |
DisclosureSEC source: 0001140859-24-000162 · wk-form4_1732225755.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 328,260.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:08 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 7,454 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000154 · wk-form4_1731532127.xml · derivative · entry 9 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,939 Underlying: Common Stock · 7,454 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F4 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F4 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:08 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 10,536 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000154 · wk-form4_1731532127.xml · derivative · entry 8 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,536 Underlying: Common Stock · 10,536 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. F3 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. F3 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:08 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 11,936 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000154 · wk-form4_1731532127.xml · derivative · entry 7 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,936 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:08 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 3,067 | $248.41 | $761,873.47 |
DisclosureSEC source: 0001140859-24-000154 · wk-form4_1731532127.xml · nonDerivative · entry 6 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,751.665 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:08 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 7,454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000154 · wk-form4_1731532127.xml · nonDerivative · entry 5 COLLIS STEVEN H · CIK 0001191508 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,818.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.